Search results
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
Zacks via Yahoo Finance· 3 weeks agoBausch Health BHC, along with its gastroenterology business, Salix Pharmaceuticals, Inc., announced...
TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down
Zacks via Yahoo Finance· 1 year agoTeva Pharmaceutical Industries Limited TEVA reported fourth-quarter 2022 adjusted earnings of 71...
3 Generic Drug Stocks to Watch Amid Macro Headwinds
Zacks via Yahoo Finance· 1 year agoThe impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and...
Bausch (BHC) Down on Tentative Approval to Xifaxan ANDA
Zacks via Yahoo Finance· 11 months agoShares of Bausch Health Companies Inc. BHC were down 8.69% on Jun 6 after the FDA granted tentative...
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
Zacks via Yahoo Finance· 6 months agoThe impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually...
Bausch (BHC) to Appeal Regarding Xifaxan Patent Decision
Zacks via Yahoo Finance· 2 years agoBausch Health Companies Inc. BHC has announced that it will appeal to the U.S. Court of Appeals for...
TEVA Q2 Earnings & Sales Top as Austedo Outperforms, Stock Up
Zacks via Yahoo Finance· 9 months agoTeva Pharmaceutical Industries Limited TEVA reported second-quarter 2023 adjusted earnings of 56...
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
Benzinga via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals Inc (NASDAQ: CPRX) has received a Notice Letter stating that Teva...